Harriet de Wit
Directeur/Bestuurslid bij PHARMALA BIOTECH HOLDINGS INC.
Vermogen: 14 600 $ op 31-05-2024
Actieve functies van Harriet de Wit
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| PHARMALA BIOTECH HOLDINGS INC. | Directeur/Bestuurslid | 21-03-2021 | - |
| The University of Chicago | Corporate Officer/Principal | - | - |
Pharmala Biotech, Inc.
 Pharmala Biotech, Inc. BiotechnologyHealth Technology Part of Pharmala Biotech Holdings, Inc., Pharmala Biotech, Inc. is a Canadian biotechnology company that manufactures and sells MDMA and MDXX class molecules. The company is based in Toronto, Canada. The company was founded by Nicholas Kadysh. Nicholas Kadysh has been the CEO since incorporation. | Directeur/Bestuurslid | - | - |
Loopbaan van Harriet de Wit
Opleiding van Harriet de Wit
| Concordia University | Doctorate Degree |
| University of Calgary | Undergraduate Degree |
Statistieken
Internationaal
| Canada | 5 |
| Verenigde Staten | 2 |
Operationeel
| Director/Board Member | 2 |
| Corporate Officer/Principal | 1 |
| Undergraduate Degree | 1 |
Sectoraal
| Consumer Services | 4 |
| Health Technology | 3 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| PHARMALA BIOTECH HOLDINGS INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Pharmala Biotech, Inc.
Pharmala Biotech, Inc. BiotechnologyHealth Technology Part of Pharmala Biotech Holdings, Inc., Pharmala Biotech, Inc. is a Canadian biotechnology company that manufactures and sells MDMA and MDXX class molecules. The company is based in Toronto, Canada. The company was founded by Nicholas Kadysh. Nicholas Kadysh has been the CEO since incorporation. | Health Technology |
- Beurs
- Insiders
- Harriet de Wit
- Ervaring
